Bartsch R, Marhold M, Garde-Noguera J, Gion M, et al. Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial. Lancet Oncol 2025;26:1467-1478.
PMID: 41167215